Global Influenza Vaccine Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Influenza Vaccine Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Influenza Vaccine by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Influenza Vaccine by Country/Region, 2017, 2022 & 2028

2.2 Influenza Vaccine Segment by Type

2.2.1 Trivalent Influenza Vaccine

2.2.2 Quadrivalent Influenza Vaccine

2.3 Influenza Vaccine Sales by Type

2.3.1 Global Influenza Vaccine Sales Market Share by Type (2017-2022)

2.3.2 Global Influenza Vaccine Revenue and Market Share by Type (2017-2022)

2.3.3 Global Influenza Vaccine Sale Price by Type (2017-2022)

2.4 Influenza Vaccine Segment by Application

2.4.1 6 Months to 3 Years

2.4.2 > 3 Years

2.5 Influenza Vaccine Sales by Application

2.5.1 Global Influenza Vaccine Sale Market Share by Application (2017-2022)

2.5.2 Global Influenza Vaccine Revenue and Market Share by Application (2017-2022)

2.5.3 Global Influenza Vaccine Sale Price by Application (2017-2022)

3 Global Influenza Vaccine by Company

3.1 Global Influenza Vaccine Breakdown Data by Company

3.1.1 Global Influenza Vaccine Annual Sales by Company (2020-2022)

3.1.2 Global Influenza Vaccine Sales Market Share by Company (2020-2022)

3.2 Global Influenza Vaccine Annual Revenue by Company (2020-2022)

3.2.1 Global Influenza Vaccine Revenue by Company (2020-2022)

3.2.2 Global Influenza Vaccine Revenue Market Share by Company (2020-2022)

3.3 Global Influenza Vaccine Sale Price by Company

3.4 Key Manufacturers Influenza Vaccine Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Influenza Vaccine Product Location Distribution

3.4.2 Players Influenza Vaccine Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Influenza Vaccine by Geographic Region

4.1 World Historic Influenza Vaccine Market Size by Geographic Region (2017-2022)

4.1.1 Global Influenza Vaccine Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Influenza Vaccine Annual Revenue by Geographic Region

4.2 World Historic Influenza Vaccine Market Size by Country/Region (2017-2022)

4.2.1 Global Influenza Vaccine Annual Sales by Country/Region (2017-2022)

4.2.2 Global Influenza Vaccine Annual Revenue by Country/Region

4.3 Americas Influenza Vaccine Sales Growth

4.4 APAC Influenza Vaccine Sales Growth

4.5 Europe Influenza Vaccine Sales Growth

4.6 Middle East & Africa Influenza Vaccine Sales Growth

5 Americas

5.1 Americas Influenza Vaccine Sales by Country

5.1.1 Americas Influenza Vaccine Sales by Country (2017-2022)

5.1.2 Americas Influenza Vaccine Revenue by Country (2017-2022)

5.2 Americas Influenza Vaccine Sales by Type

5.3 Americas Influenza Vaccine Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Influenza Vaccine Sales by Region

6.1.1 APAC Influenza Vaccine Sales by Region (2017-2022)

6.1.2 APAC Influenza Vaccine Revenue by Region (2017-2022)

6.2 APAC Influenza Vaccine Sales by Type

6.3 APAC Influenza Vaccine Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Influenza Vaccine by Country

7.1.1 Europe Influenza Vaccine Sales by Country (2017-2022)

7.1.2 Europe Influenza Vaccine Revenue by Country (2017-2022)

7.2 Europe Influenza Vaccine Sales by Type

7.3 Europe Influenza Vaccine Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Influenza Vaccine by Country

8.1.1 Middle East & Africa Influenza Vaccine Sales by Country (2017-2022)

8.1.2 Middle East & Africa Influenza Vaccine Revenue by Country (2017-2022)

8.2 Middle East & Africa Influenza Vaccine Sales by Type

8.3 Middle East & Africa Influenza Vaccine Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Influenza Vaccine

10.3 Manufacturing Process Analysis of Influenza Vaccine

10.4 Industry Chain Structure of Influenza Vaccine

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Influenza Vaccine Distributors

11.3 Influenza Vaccine Customer

12 World Forecast Review for Influenza Vaccine by Geographic Region

12.1 Global Influenza Vaccine Market Size Forecast by Region

12.1.1 Global Influenza Vaccine Forecast by Region (2023-2028)

12.1.2 Global Influenza Vaccine Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Influenza Vaccine Forecast by Type

12.7 Global Influenza Vaccine Forecast by Application

13 Key Players Analysis

13.1 Sanofi

13.1.1 Sanofi Company Information

13.1.2 Sanofi Influenza Vaccine Product Offered

13.1.3 Sanofi Influenza Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Sanofi Main Business Overview

13.1.5 Sanofi Latest Developments

13.2 CSL

13.2.1 CSL Company Information

13.2.2 CSL Influenza Vaccine Product Offered

13.2.3 CSL Influenza Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 CSL Main Business Overview

13.2.5 CSL Latest Developments

13.3 GSK

13.3.1 GSK Company Information

13.3.2 GSK Influenza Vaccine Product Offered

13.3.3 GSK Influenza Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 GSK Main Business Overview

13.3.5 GSK Latest Developments

13.4 Viatris

13.4.1 Viatris Company Information

13.4.2 Viatris Influenza Vaccine Product Offered

13.4.3 Viatris Influenza Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Viatris Main Business Overview

13.4.5 Viatris Latest Developments

13.5 AstraZeneca

13.5.1 AstraZeneca Company Information

13.5.2 AstraZeneca Influenza Vaccine Product Offered

13.5.3 AstraZeneca Influenza Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 AstraZeneca Main Business Overview

13.5.5 AstraZeneca Latest Developments

13.6 Hualan Bio

13.6.1 Hualan Bio Company Information

13.6.2 Hualan Bio Influenza Vaccine Product Offered

13.6.3 Hualan Bio Influenza Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Hualan Bio Main Business Overview

13.6.5 Hualan Bio Latest Developments

13.7 Changchun Institute of Biological

13.7.1 Changchun Institute of Biological Company Information

13.7.2 Changchun Institute of Biological Influenza Vaccine Product Offered

13.7.3 Changchun Institute of Biological Influenza Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Changchun Institute of Biological Main Business Overview

13.7.5 Changchun Institute of Biological Latest Developments

13.8 Sinovac

13.8.1 Sinovac Company Information

13.8.2 Sinovac Influenza Vaccine Product Offered

13.8.3 Sinovac Influenza Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Sinovac Main Business Overview

13.8.5 Sinovac Latest Developments

13.9 BCHT

13.9.1 BCHT Company Information

13.9.2 BCHT Influenza Vaccine Product Offered

13.9.3 BCHT Influenza Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 BCHT Main Business Overview

13.9.5 BCHT Latest Developments

13.10 Jiangsu GDK

13.10.1 Jiangsu GDK Company Information

13.10.2 Jiangsu GDK Influenza Vaccine Product Offered

13.10.3 Jiangsu GDK Influenza Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Jiangsu GDK Main Business Overview

13.10.5 Jiangsu GDK Latest Developments

13.11 KM Biologics

13.11.1 KM Biologics Company Information

13.11.2 KM Biologics Influenza Vaccine Product Offered

13.11.3 KM Biologics Influenza Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 KM Biologics Main Business Overview

13.11.5 KM Biologics Latest Developments

14 Research Findings and Conclusion

Table 1. Influenza Vaccine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Influenza Vaccine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Trivalent Influenza Vaccine

Table 4. Major Players of Quadrivalent Influenza Vaccine

Table 5. Global Influenza Vaccine Sales by Type (2017-2022) & (M Doses)

Table 6. Global Influenza Vaccine Sales Market Share by Type (2017-2022)

Table 7. Global Influenza Vaccine Revenue by Type (2017-2022) & ($ million)

Table 8. Global Influenza Vaccine Revenue Market Share by Type (2017-2022)

Table 9. Global Influenza Vaccine Sale Price by Type (2017-2022) & (USD/Doses)

Table 10. Global Influenza Vaccine Sales by Application (2017-2022) & (M Doses)

Table 11. Global Influenza Vaccine Sales Market Share by Application (2017-2022)

Table 12. Global Influenza Vaccine Revenue by Application (2017-2022)

Table 13. Global Influenza Vaccine Revenue Market Share by Application (2017-2022)

Table 14. Global Influenza Vaccine Sale Price by Application (2017-2022) & (USD/Doses)

Table 15. Global Influenza Vaccine Sales by Company (2020-2022) & (M Doses)

Table 16. Global Influenza Vaccine Sales Market Share by Company (2020-2022)

Table 17. Global Influenza Vaccine Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Influenza Vaccine Revenue Market Share by Company (2020-2022)

Table 19. Global Influenza Vaccine Sale Price by Company (2020-2022) & (USD/Doses)

Table 20. Key Manufacturers Influenza Vaccine Producing Area Distribution and Sales Area

Table 21. Players Influenza Vaccine Products Offered

Table 22. Influenza Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Influenza Vaccine Sales by Geographic Region (2017-2022) & (M Doses)

Table 26. Global Influenza Vaccine Sales Market Share Geographic Region (2017-2022)

Table 27. Global Influenza Vaccine Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Influenza Vaccine Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Influenza Vaccine Sales by Country/Region (2017-2022) & (M Doses)

Table 30. Global Influenza Vaccine Sales Market Share by Country/Region (2017-2022)

Table 31. Global Influenza Vaccine Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Influenza Vaccine Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Influenza Vaccine Sales by Country (2017-2022) & (M Doses)

Table 34. Americas Influenza Vaccine Sales Market Share by Country (2017-2022)

Table 35. Americas Influenza Vaccine Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Influenza Vaccine Revenue Market Share by Country (2017-2022)

Table 37. Americas Influenza Vaccine Sales by Type (2017-2022) & (M Doses)

Table 38. Americas Influenza Vaccine Sales Market Share by Type (2017-2022)

Table 39. Americas Influenza Vaccine Sales by Application (2017-2022) & (M Doses)

Table 40. Americas Influenza Vaccine Sales Market Share by Application (2017-2022)

Table 41. APAC Influenza Vaccine Sales by Region (2017-2022) & (M Doses)

Table 42. APAC Influenza Vaccine Sales Market Share by Region (2017-2022)

Table 43. APAC Influenza Vaccine Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Influenza Vaccine Revenue Market Share by Region (2017-2022)

Table 45. APAC Influenza Vaccine Sales by Type (2017-2022) & (M Doses)

Table 46. APAC Influenza Vaccine Sales Market Share by Type (2017-2022)

Table 47. APAC Influenza Vaccine Sales by Application (2017-2022) & (M Doses)

Table 48. APAC Influenza Vaccine Sales Market Share by Application (2017-2022)

Table 49. Europe Influenza Vaccine Sales by Country (2017-2022) & (M Doses)

Table 50. Europe Influenza Vaccine Sales Market Share by Country (2017-2022)

Table 51. Europe Influenza Vaccine Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Influenza Vaccine Revenue Market Share by Country (2017-2022)

Table 53. Europe Influenza Vaccine Sales by Type (2017-2022) & (M Doses)

Table 54. Europe Influenza Vaccine Sales Market Share by Type (2017-2022)

Table 55. Europe Influenza Vaccine Sales by Application (2017-2022) & (M Doses)

Table 56. Europe Influenza Vaccine Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Influenza Vaccine Sales by Country (2017-2022) & (M Doses)

Table 58. Middle East & Africa Influenza Vaccine Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Influenza Vaccine Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Influenza Vaccine Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Influenza Vaccine Sales by Type (2017-2022) & (M Doses)

Table 62. Middle East & Africa Influenza Vaccine Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Influenza Vaccine Sales by Application (2017-2022) & (M Doses)

Table 64. Middle East & Africa Influenza Vaccine Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Influenza Vaccine

Table 66. Key Market Challenges & Risks of Influenza Vaccine

Table 67. Key Industry Trends of Influenza Vaccine

Table 68. Influenza Vaccine Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Influenza Vaccine Distributors List

Table 71. Influenza Vaccine Customer List

Table 72. Global Influenza Vaccine Sales Forecast by Region (2023-2028) & (M Doses)

Table 73. Global Influenza Vaccine Sales Market Forecast by Region

Table 74. Global Influenza Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Influenza Vaccine Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Influenza Vaccine Sales Forecast by Country (2023-2028) & (M Doses)

Table 77. Americas Influenza Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Influenza Vaccine Sales Forecast by Region (2023-2028) & (M Doses)

Table 79. APAC Influenza Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Influenza Vaccine Sales Forecast by Country (2023-2028) & (M Doses)

Table 81. Europe Influenza Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Influenza Vaccine Sales Forecast by Country (2023-2028) & (M Doses)

Table 83. Middle East & Africa Influenza Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Influenza Vaccine Sales Forecast by Type (2023-2028) & (M Doses)

Table 85. Global Influenza Vaccine Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Influenza Vaccine Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Influenza Vaccine Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Influenza Vaccine Sales Forecast by Application (2023-2028) & (M Doses)

Table 89. Global Influenza Vaccine Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Influenza Vaccine Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Influenza Vaccine Revenue Market Share Forecast by Application (2023-2028)

Table 92. Sanofi Basic Information, Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 93. Sanofi Influenza Vaccine Product Offered

Table 94. Sanofi Influenza Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2022)

Table 95. Sanofi Main Business

Table 96. Sanofi Latest Developments

Table 97. CSL Basic Information, Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 98. CSL Influenza Vaccine Product Offered

Table 99. CSL Influenza Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2022)

Table 100. CSL Main Business

Table 101. CSL Latest Developments

Table 102. GSK Basic Information, Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 103. GSK Influenza Vaccine Product Offered

Table 104. GSK Influenza Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2022)

Table 105. GSK Main Business

Table 106. GSK Latest Developments

Table 107. Viatris Basic Information, Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 108. Viatris Influenza Vaccine Product Offered

Table 109. Viatris Influenza Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2022)

Table 110. Viatris Main Business

Table 111. Viatris Latest Developments

Table 112. AstraZeneca Basic Information, Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 113. AstraZeneca Influenza Vaccine Product Offered

Table 114. AstraZeneca Influenza Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2022)

Table 115. AstraZeneca Main Business

Table 116. AstraZeneca Latest Developments

Table 117. Hualan Bio Basic Information, Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 118. Hualan Bio Influenza Vaccine Product Offered

Table 119. Hualan Bio Influenza Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2022)

Table 120. Hualan Bio Main Business

Table 121. Hualan Bio Latest Developments

Table 122. Changchun Institute of Biological Basic Information, Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 123. Changchun Institute of Biological Influenza Vaccine Product Offered

Table 124. Changchun Institute of Biological Influenza Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2022)

Table 125. Changchun Institute of Biological Main Business

Table 126. Changchun Institute of Biological Latest Developments

Table 127. Sinovac Basic Information, Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 128. Sinovac Influenza Vaccine Product Offered

Table 129. Sinovac Influenza Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2022)

Table 130. Sinovac Main Business

Table 131. Sinovac Latest Developments

Table 132. BCHT Basic Information, Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 133. BCHT Influenza Vaccine Product Offered

Table 134. BCHT Influenza Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2022)

Table 135. BCHT Main Business

Table 136. BCHT Latest Developments

Table 137. Jiangsu GDK Basic Information, Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 138. Jiangsu GDK Influenza Vaccine Product Offered

Table 139. Jiangsu GDK Influenza Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2022)

Table 140. Jiangsu GDK Main Business

Table 141. Jiangsu GDK Latest Developments

Table 142. KM Biologics Basic Information, Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 143. KM Biologics Influenza Vaccine Product Offered

Table 144. KM Biologics Influenza Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2022)

Table 145. KM Biologics Main Business

Table 146. KM Biologics Latest Developments

List of Figures

Figure 1. Picture of Influenza Vaccine

Figure 2. Influenza Vaccine Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Influenza Vaccine Sales Growth Rate 2017-2028 (M Doses)

Figure 7. Global Influenza Vaccine Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Influenza Vaccine Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Trivalent Influenza Vaccine

Figure 10. Product Picture of Quadrivalent Influenza Vaccine

Figure 11. Global Influenza Vaccine Sales Market Share by Type in 2021

Figure 12. Global Influenza Vaccine Revenue Market Share by Type (2017-2022)

Figure 13. Influenza Vaccine Consumed in 6 Months to 3 Years

Figure 14. Global Influenza Vaccine Market: 6 Months to 3 Years (2017-2022) & (M Doses)

Figure 15. Influenza Vaccine Consumed in > 3 Years

Figure 16. Global Influenza Vaccine Market: > 3 Years (2017-2022) & (M Doses)

Figure 17. Global Influenza Vaccine Sales Market Share by Application (2017-2022)

Figure 18. Global Influenza Vaccine Revenue Market Share by Application in 2021

Figure 19. Influenza Vaccine Revenue Market by Company in 2021 ($ Million)

Figure 20. Global Influenza Vaccine Revenue Market Share by Company in 2021

Figure 21. Global Influenza Vaccine Sales Market Share by Geographic Region (2017-2022)

Figure 22. Global Influenza Vaccine Revenue Market Share by Geographic Region in 2021

Figure 23. Global Influenza Vaccine Sales Market Share by Region (2017-2022)

Figure 24. Global Influenza Vaccine Revenue Market Share by Country/Region in 2021

Figure 25. Americas Influenza Vaccine Sales 2017-2022 (M Doses)

Figure 26. Americas Influenza Vaccine Revenue 2017-2022 ($ Millions)

Figure 27. APAC Influenza Vaccine Sales 2017-2022 (M Doses)

Figure 28. APAC Influenza Vaccine Revenue 2017-2022 ($ Millions)

Figure 29. Europe Influenza Vaccine Sales 2017-2022 (M Doses)

Figure 30. Europe Influenza Vaccine Revenue 2017-2022 ($ Millions)

Figure 31. Middle East & Africa Influenza Vaccine Sales 2017-2022 (M Doses)

Figure 32. Middle East & Africa Influenza Vaccine Revenue 2017-2022 ($ Millions)

Figure 33. Americas Influenza Vaccine Sales Market Share by Country in 2021

Figure 34. Americas Influenza Vaccine Revenue Market Share by Country in 2021

Figure 35. United States Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 36. Canada Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 37. Mexico Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 38. Brazil Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 39. APAC Influenza Vaccine Sales Market Share by Region in 2021

Figure 40. APAC Influenza Vaccine Revenue Market Share by Regions in 2021

Figure 41. China Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 42. Japan Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 43. South Korea Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 44. Southeast Asia Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 45. India Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 46. Australia Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 47. Europe Influenza Vaccine Sales Market Share by Country in 2021

Figure 48. Europe Influenza Vaccine Revenue Market Share by Country in 2021

Figure 49. Germany Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 50. France Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 51. UK Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 52. Italy Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 53. Russia Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 54. Middle East & Africa Influenza Vaccine Sales Market Share by Country in 2021

Figure 55. Middle East & Africa Influenza Vaccine Revenue Market Share by Country in 2021

Figure 56. Egypt Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 57. South Africa Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 58. Israel Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 59. Turkey Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 60. GCC Country Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 61. Manufacturing Cost Structure Analysis of Influenza Vaccine in 2021

Figure 62. Manufacturing Process Analysis of Influenza Vaccine

Figure 63. Industry Chain Structure of Influenza Vaccine

Figure 64. Channels of Distribution

Figure 65. Distributors Profiles